Uncovering Symptom Progression History from Disease Registry Data with Application to Young Cystic Fibrosis Patients

被引:3
|
作者
Yan, Jun [1 ,2 ]
Cheng, Yu [3 ,4 ]
Fine, Jason P. [5 ]
Lai, HuiChuan J. [6 ,7 ]
机构
[1] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA
[2] Univ Connecticut, Publ Hlth Res Inst, Storrs, CT 06269 USA
[3] Univ Pittsburgh, Dept Stat, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA
[5] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA
[6] Univ Wisconsin, Dept Nutr Sci, Dept Biostat & Med Informat, Madison, WI 53706 USA
[7] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA
基金
美国国家科学基金会;
关键词
Generalized linear model; Lung infection; Newborn screening and diagnosis; Prevalence: Pseudomonas aeruginosa; Varying coefficient; PSEUDOMONAS-AERUGINOSA INFECTION; REGRESSION; SURVIVAL; PREVALENCE; COLONIZATION; RECURRENT;
D O I
10.1111/j.1541-0420.2009.01288.x
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The growing availability of various disease registry data has brought precious opportunities to epidemiologists to understand the natural history of the registered diseases. It also presents challenges to the traditional data analysis techniques because of complicated censoring/truncation schemes and temporal dynamics of covariate influences. In a case study of the Cystic Fibrosis Foundation Patient Registry data, we propose analyses of progressive symptoms using temporal process regressions, as an alternative to the commonly employed proportional hazards models. Two endpoints are considered, the prevalence of ever positive and currently positive for Pseudomonas aeruginosa. (PA) infection in the lungs, which capture different aspect of the disease process. The analysis of ever PA positive via, a time-varying coefficient model demonstrates the lack of fit, as well as the potential loss of information, in the standard proportional hazards analysis. The analysis of currently PA positive yields results that are clinically meaningful and have not previously been reported in the cystic fibrosis literature. Our analyses demonstrate that prenatal/neonatal screening results in lower prevalence of PA infection compared to traditional diagnosis via, signs and symptoms, but this benefit attenuates with age. Calendar years of diagnosis also affect the risk of PA infection; patients diagnosed in more recent cohort show higher prevalence of ever PA positive but lower prevalence of currently PA positive.
引用
收藏
页码:594 / 602
页数:9
相关论文
共 50 条
  • [1] Cystic Fibrosis Patients Eligible for Modulator Drugs: Data from Cystic Fibrosis Registry of Turkey
    Cobanoglu, Fatma Nazan
    Ersoz, Deniz Dogru
    Cakir, Erkan
    Eyuboglu, Tugba Sismanlar
    Pekcan, Sevgi
    Cinel, Guzin
    Yalcin, Ebru
    Kiper, Nural
    Sen, Velat
    Sen, Hadice Selimoglu
    Ercan, Omur
    Keskin, Ozlem
    Eltan, Sevgi Bilgic
    Al Shadfan, Lina Muhammed
    Yazan, Hakan
    Altintas, Derya Ufuk
    Sasihuseyinoglu, Senay
    Sapan, Nihat
    Cekic, Sukru
    Cokugras, Haluk
    Atabek, Ayse Ayzit
    Gursoy, Tugba Ramasli
    Aslan, Ayse Tana
    Bingol, Aysen
    Basaran, Abdurrahman Erdem
    Ozdemir, Ali
    Kose, Mehmet
    Hangul, Melih
    Emiralioglu, Nagehan
    Tugcu, Gokcen
    Yuksel, Hasan
    Yilmaz, Ozge
    Orhan, Fazil
    Aydin, Zeynep Gokce Gayretli
    Topal, Erdem
    Tamay, Zeynep
    Suleyman, Ayse
    Can, Demet
    Bal, Cem Murat
    Caltepe, Gonul
    Ozcelik, Ugur
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [2] Perinatal outcomes in women with cystic fibrosis: Data from the Italian Cystic Fibrosis Registry
    Padoan, Rita F.
    Quattrucci, Serena
    Amato, Annalisa
    Salvatore, Marco
    Salvatore, Donatello
    Campagna, Giuseppe
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2021, 100 (08) : 1439 - 1444
  • [3] Risk factors for cystic fibrosis arthropathy: Data from the German cystic fibrosis registry
    Grehn, Claudia
    Dittrich, A-M
    Wosniok, J.
    Holz, F.
    Hafkemeyer, S.
    Naehrlich, L.
    Schwarz, C.
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (06) : E87 - E92
  • [4] Patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey
    Cobanoglu, Nazan
    Ozcelik, Ugur
    Cakir, Erkan
    Eyuboglu, Tugba Sismanlar
    Pekcan, Sevgi
    Cinel, Guzin
    Yalcin, Ebru
    Kiper, Nural
    Emiralioglu, Nagehan
    Sen, Velat
    Sen, Hadice Selimoglu
    Ercan, Omur
    Cokugras, Haluk
    Kilinc, Ayse Ayzit
    Al Shadfan, Lina Muhammed
    Yazan, Hakan
    Altintas, Derya Ufuk
    Karagoz, Dilek
    Demir, Esen
    Ozturk, Gokcen Kartal
    Bingol, Aysen
    Basaran, Abdurrahman Erdem
    Sapan, Nihat
    Cekic, Sukru
    Celebioglu, Ebru
    Aslan, Ayse Tana
    Gursoy, Tugba Ramasli
    Tugcu, Gokcen
    Ozdemir, Ali
    Harmanci, Koray
    Yildirim, Gonca Kilic
    Kose, Mehmet
    Hangul, Melih
    Tamay, Zeynep
    Suleyman, Ayse
    Yuksel, Hasan
    Yilmaz, Ozge
    Ozcan, Gizem
    Topal, Erdem
    Can, Demet
    Ekren, Pervin Korkmaz
    Caltepe, Gonul
    Kilic, Mehmet
    Ozdogan, Sebnem
    Dogru, Deniz
    PEDIATRIC PULMONOLOGY, 2020, 55 (09) : 2302 - 2306
  • [5] EXPLORING BONE DISEASE IN CYSTIC FIBROSIS USING REGISTRY DATA
    Edwards, D. K.
    Cullinan, P.
    Carr, S. B.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S235 - S236
  • [6] Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries
    Volkova, Nataliya
    Moy, Kristin
    Evans, Jennifer
    Campbell, Daniel
    Tian, Simon
    Simard, Christopher
    Higgins, Mark
    Konstan, Michael W.
    Sawicki, Gregory S.
    Elbert, Alexander
    Charman, Susan C.
    Marshall, Bruce C.
    Bilton, Diana
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (01) : 68 - 79
  • [7] Progression of Lung Disease in Preschool Patients with Cystic Fibrosis
    Stanojevic, Sanja
    Davis, Stephanie D.
    Retsch-Bogart, George
    Webster, Hailey
    Davis, Miriam
    Johnson, Robin C.
    Jensen, Renee
    Ester Pizarro, Maria
    Kane, Mica
    Clem, Charles C.
    Schornick, Leah
    Subbarao, Padmaja
    Ratjen, Felix A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (09) : 1216 - 1225
  • [8] Glucose Tolerance in Patients with Cystic Fibrosis - Results from the German Cystic Fibrosis Registry
    Prinz, Nicole
    Wosniok, Julia
    Staab, Doris
    Ballmann, Manfred
    Dopfer, Christian
    Regenfuss, Nicole
    Rosenecker, Josef
    Schramm, Dirk
    Holl, Reinhard W.
    Naehrlich, Lutz
    KLINISCHE PADIATRIE, 2020, 232 (04): : 210 - 216
  • [9] International practice patterns by age and severity of lung disease in cystic fibrosis: Data from the Epidemiologic Registry of Cystic Fibrosis (ERCF)
    Koch, C
    McKenzie, SG
    Kaplowitz, H
    Hodson, ME
    Harms, HK
    Navarro, J
    Mastella, G
    PEDIATRIC PULMONOLOGY, 1997, 24 (02) : 147 - 154
  • [10] Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosis
    Harriet Corvol
    Nadia Nathan
    Celine Charlier
    Katarina Chadelat
    Philippe Le Rouzic
    Olivier Tabary
    Brigitte Fauroux
    Alexandra Henrion-Caude
    Josue Feingold
    Pierre-Yves Boelle
    Annick Clement
    Respiratory Research, 8